常染色体显性多囊肾病患者中的转移性肾细胞癌
Metastatic Renal Cell Carcinoma in a Patient With Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · Clin Nucl Med · 2024-01-23
本文报告一例常染色体显性多囊肾病(ADPKD)患者继发肾细胞癌并伴肺部转移恶化的FDG PET/CT表现;原发肾肿瘤在对比增强CT上无可疑特征,但FDG摄取强烈。ADPKD患者发生肾细胞癌的风险增高。
要点
- ADPKD患者发生肾细胞癌的风险增高。
- 本例原发肾肿瘤在对比增强CT上无可疑特征,但FDG摄取强烈。
- FDG PET/CT显示肾细胞癌继发于ADPKD并伴肺部转移恶化。
核心结论
- ADPKD患者发生肾细胞癌的风险增高,本例FDG PET/CT显示继发于ADPKD的肾细胞癌伴肺部转移恶化。
研究设计与样本
- 本文为病例报告,展示一例继发于ADPKD的肾细胞癌伴肺部转移恶化患者的FDG PET/CT表现。
主要发现
- 原发肾肿瘤在对比增强CT上无可疑特征,但FDG摄取强烈。
- 患者肾细胞癌继发于ADPKD,并并发肺部转移恶化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD) manifests as multiple cysts in the kidneys and liver but can also present with musculoskeletal and cardiovascular abnormalities. ADPKD patients are at increased risk for renal cell carcinoma development. We show the FDG PET/CT findings in a patient with renal cell carcinoma secondary to ADPKD and complicated by worsening pulmonary metastasis. The primary renal tumor shows intense FDG uptake despite no suspicious features with contrast CT.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Rumrill WM, Ballard DH. Metastatic Renal Cell Carcinoma in a Patient With Autosomal Dominant Polycystic Kidney Disease. Clin Nucl Med. 2024. PMID: 38271253. doi:10.1097/RLU.0000000000005059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。